Zelira Therapeutics Ltd.ASX: ZLD

HOPE SPV receives US$819,000 second tranche of funding

· Issued by Zelira Therapeutics Ltd.

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Zelira Therapeutics Ltd. has announced the receipt of a second tranche of funding for its HOPE® SPV, amounting to a significant sum from the Forman Trust. To date, the total funds received by the HOPE® SPV have reached a notable amount, enhancing Zelira's financial backing for its clinical programs.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zelira Therapeutics Ltd. on 6ix

Earlier from Zelira Therapeutics

Later from Zelira Therapeutics

All Zelira Therapeutics news releases